COVID-19, kidney management among top CKD-related news stories in 2023
Click Here to Manage Email Alerts
Healio has compiled a list of its most-read chronic kidney disease care news in 2023.
The impact of COVID-19 on chronic kidney disease treatment piqued readers’ interest, as did stories about conservative kidney management vs. dialysis and CKD in children.
COVID-19 increased rapid kidney function decline in patients with CKD
Among patients with stages 3-4 chronic kidney disease, COVID-19 infection increased the odds of rapid kidney function decline during the pandemic, according to a study. Read more.
Study: Conservative kidney management may be viable alternative to dialysis to treat CKD
Conservative kidney management may be a viable treatment for patients with chronic kidney disease, but researchers found not many patients are aware of the therapy. Read more.
Children with CKD experience increased burden of fatigue independent of disease severity
Regardless of chronic kidney disease stage, children experience high and consistent burden of impairment across many patient-reported measures, according to data published in the American Journal of Kidney Disease. Read more.
Trial results show gout therapy of pegloticase, methotrexate maintained eGFR vs. placebo
Results from a poster presentation here showed that patients with uncontrolled gout treated with the combined therapy of pegloticase and methotrexate saw a reduction in gout symptoms, as well as a stable eGFR. Read more.
Lower mortality rates found for patients using hemodiafiltration vs. high-flux dialysis
Results from a study completed in eight European countries showed that patients receiving high-dose hemodiafiltration had lower mortality vs. patients using high-flux dialysis. Read more.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts